Trials so far are small and sometimes inconclusive, and the ideal dose, schedule, and stacking approach remain open questions
If you are experiencing severe side effects from your GLP-1 medication and cannot reach your provider for days, that is a genuine safety concern
Thus, a number of unforeseen interactions are emerging between primary and so-called secondary metabolism, which may result in new anti-fungal drug target identification
While beneficial microbes and postbiotics enhance GLP-1 activity to support metabolic homeostasis, pathogenic species and harmful metabolites may inhibit this pathway, contributing to disease progression
The results showed that Nrf2 was absent in PF areas, while the SalB treatment could increase the expression of Nrf2 in lung tissues
C., Hicklin, D